Methylphenidate Hydrochloride Extended-Release 36 mg/1

Methylphenidate Hydrochloride Extended-Release 36 mg/1 is a medication used to manage certain conditions. This extended-release tablet is designed for oral administration and is manufactured by SpecGx LLC in the USA.

Methylphenidate Hydrochloride Extended-Release 36 mg/1 is commonly used for conditions that require sustained attention and focus. It is often prescribed to help manage symptoms associated with attention deficit hyperactivity disorder (ADHD). The extended-release formulation is designed to provide a prolonged effect, which can help maintain consistent levels of the medication in the body throughout the day.

Methylphenidate Hydrochloride Extended-Release 36 mg/1 may cause various effects, including increased alertness and concentration. Some users may experience side effects such as decreased appetite, insomnia, or mild gastrointestinal discomfort. The extended-release formulation is designed to minimize fluctuations in drug levels, which can help reduce the severity of side effects.

It is important to handle Methylphenidate Hydrochloride Extended-Release 36 mg/1 with care. This medication should be stored at room temperature and kept out of reach of children. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release tablets, as this can alter the drug's release mechanism.

Methylphenidate Hydrochloride Extended-Release 36 mg/1 may interact with certain substances, including alcohol and other stimulants. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. Some medications, such as monoamine oxidase inhibitors (MAOIs), can have serious interactions with methylphenidate and should be avoided.